x-cardiac GmbH develops AI-based systems for the prediction of life-threatening complications after cardiac surgery. The software was developed by Prof. Alexander Meyer, clinician and computer scientist at the German Heart Center Berlin (DHZB), and has been trained using anonymized data from c. 32,000 patient admissions at the DHZB/DHZC, with over 750 million data points. The funds from this financing round will be used to further develop the x-cardiac platform and drive the market launch of medical products x-c-bleeding and x-c-renal-injury for the early detection of postoperative bleeding and acute renal failure, respectively.
CEO Oliver Höppner is delighted: ‘Digitalization in daily clinical routine is making huge strides, and x-cardiac can make a big contribution. We have been able to demonstrate this successfully with our initial pilot customers, and would now like to offer our medical products to further cardiology clinics.’
The DHZB, the Berlin Institute of Health (BIH) and the Charité – Universitätsmedizin Berlin supported the founding of x-cardiac. Ascenion GmbH, technology transfer partner of Charité and BIH, hold shares in the start-up.
Further information:
German press release from IBB Ventures
Search results
Ascenion’s portfolio company x-cardiac successfully closes further financing round
The Berlin start-up develops AI-based software for predicting complications after major cardiac surgery. New business angels and family offices have now invested in the company, alongside the existing investor consortium around IBB Ventures.